- Report
- September 2024
- 375 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
Global
From €2329EUR$2,450USD£1,957GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 898 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 272 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 131 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Drug Pipelines
- March 2025
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2025
- 194 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- November 2024
- 240 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- October 2024
- 212 Pages
Global
From €7558EUR$7,950USD£6,349GBP

The Blood Brain Barrier (BBB) is a specialized membrane that separates the brain from the rest of the body. It is composed of tightly packed cells that form a barrier to protect the brain from potentially harmful substances. The BBB is an important factor in the development of Central Nervous System (CNS) drugs, as it can limit the effectiveness of certain drugs. To overcome this, drug developers must create drugs that can cross the BBB and reach the target area in the brain. This requires a deep understanding of the BBB and its components, as well as the development of new drug delivery systems.
The BBB market is an important part of the CNS drug market, as it provides the necessary tools to develop effective drugs. Companies in this market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more